Journal
BRITISH JOURNAL OF PSYCHIATRY
Volume 182, Issue -, Pages 492-497Publisher
ROYAL COLLEGE OF PSYCHIATRISTS
DOI: 10.1192/bjp.182.6.492
Keywords
-
Categories
Ask authors/readers for more resources
Background Despite a growing use of selective serotonin reuptake inhibitors in older people, only one trial has examined their prophylactic efficacy in people aged 65 years and over. Aims To examine the efficacy of sertraline in preventing the recurrence of depression in older people living in the community Method Participants were openly treated with sertraline and then randomised into a double-blind, placebo-controlled continuation/maintenance study of about 2 years duration. Drug dosage was maintained at levels that achieved remission. Results No significant difference between the sertraline and placebo groups was found in the proportion of recurrences (- 7.9%; 95% Cl -28.06 to 12.23). Increased age and minor residual symptoms during the continuation phase were associated with recurrence. Conclusions Sertraline at therapeutic dosage does not provide significant protection against recurrence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available